For the remaining analyses, only miR-7-5p was used for the evaluation of all samples from patients with expressions of the BCR::ABL1 transcript (30 samples) and in the group of samples from CML patients with undetectable levels of BCR::ABL1 transcripts (20 samples), as well as samples from healthy controls (Figure 3). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.